The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Fairview, U of Minnesota Finalize New 10-Year Partnership

University of Minnesota, Minneapolis-based Fairview Health Services and University of Minnesota Physicians have finalized agreements cementing a new 10-year partnership, according to Becker's Hospital Review. The deal takes effect Jan. 1, 2027, when the parties' current 30-year agreement expires, and preserves their intertwined academic, research and clinical relationship.

The agreements operationalize a mediated deal reached in January, putting concrete terms behind a high-profile relationship that had grown strained. Tensions peaked after Fairview's proposed 2022 merger with South Dakota-based Sanford Health collapsed amid opposition from the university and state officials, raising questions about who would control the academic medical enterprise and its flagship facilities.

Leaders framed the new pact as offering "much needed clarity and a path to restore trust." In practice, it locks in a decade of stability for clinical operations, medical education and research tied to the university's academic health center, and signals that the three organizations intend to repair a partnership that nearly fractured rather than pursue separate paths.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.